pharma

100 million Indians could be on GLP-1 drugs by 2030: Healthify CEO

” We are doing $1-2 million run rate revenue in the US. We expect the US business to be larger…

Updated: December 3, 2025 22:36 IST

Sudeep Pharma Share Price, IPO GMP, Listing Live Updates

Highlights: Sudeep Pharma lists at a 24% premium to the issue price – Here’s all you need to know

Sudeep Pharma Share Price, IPO Listing Live | Sudeep Pharma IPO GMP Live Updates: Sudeep Pharma debuts on stock exchanges…

Updated: November 28, 2025 15:44 IST

Divi’s, Syngene, Laurus and Cohance to lead India’s $15.4 billion CRDMO boom: JPMorgan

Divi’s, Syngene & Laurus: 6 stocks JPMorgan says will lead India’s $15.4 billion CRDMO boom

JPMorgan says India’s CRDMO market will grow to $15.4 billion by 2029, driven by China+1, regulatory edge and cost advantage,…

November 26, 2025 09:23 IST

Sudeep Pharma IPO GMP, subscription, allotment, today, November 21

Sudeep Pharma IPO opens today: Check GMP, subscription, and 5 critical details

Sudeep Pharma IPO opens for subscription, aiming to raise Rs 895 crore; check price, GMP, and allotment dates—apply now for…

November 21, 2025 06:00 IST

The Trump effect: How Indian pharma’s ‘beyond US’ bet is finally paying off

Indian pharma exporters had for several months faced the rhetoric and threats from the Trump administration to impose tariffs on…

November 11, 2025 05:30 IST

Buy these stocks in November and sell in December

Seasonality suggests November softness and December strength, yet select Pharma counters consistently outperform. Three stocks offering the favourable risk-reward from…

November 11, 2025 05:30 IST

Layoffs 2025: The job cuts follow similar moves by Oracle, Microsoft, and other companies that have recently let go of thousands of employees.

Novo Nordisk partners Emcure Pharma for weight loss medicine Poviztra in India

This collaboration combines Novo Nordisk’s innovation in GLP-1 therapies with Emcure’s marketing and distribution strengths to improve access to obesity…

November 10, 2025 23:17 IST

WHO issues health alert after death of 20 children linked to Coldrif cough syrup

Cough syrup sales fall marginally in October over safety concerns

According to Pharmarack, unlike the previous two years where October sales for Oral Rehydration Solutions (ORS) is lesser than September…

November 10, 2025 20:55 IST

Cipla to market Eli Lilly’s weight-loss drug

India has about 101 million people living with diabetes and nearly half of these in the adult patients category are…

October 23, 2025 23:40 IST

Doctor raises alarm over Trump’s secret MRI, calls for White House transparency

New drug tariffs coming soon? Trump administration plans new probe into pharma pricing, says report

President Donald Trump’s administration is reportedly preparing a new Section 301 investigation into whether US trading partners are underpaying for…

Updated: October 22, 2025 17:24 IST

Indian pharma stocks gain as US Senate passes Biosecure Act under NDAA bill

Pharma sector poised to grow at 9% through FY30: Care Ratings

In the exports segment, as per Care Ratings, the regulated markets (US, European Union) are expected to maintain strong growth…

October 16, 2025 22:38 IST

Global market cues; Asian markets, oil and 8 other cues at this hour

Market Watchlist: Will earnings spark the breakout everyone’s waiting for? HDFC Bank, Tata Steel, Bajaj Finance among 9 stocks to watch

Market watchlist this week, October 12: Track key stocks like HDFC Bank, Tata Steel, and Bajaj Finance as earnings season…

October 13, 2025 05:30 IST

India's Revised PRIP Scheme: A Boost for Pharma R&D or Still Falling Short of Novel Drug Dreams?

Faster GST refunds a boon for pharma and MedTech units

In early September, the government slashed GST rates on all pharmaceutical formulations from 12% to 5%. Exemptions were also provided…

October 10, 2025 23:21 IST

Meet India’s new rich: Younger, bolder, and building from scratch

With 1,115 self-made entrepreneurs and 358 billionaires, India’s new rich are rewriting the rules of wealth creation. From AI founders…

October 8, 2025 05:30 IST

Pharma Stocks Slump on US 100% Tariff News, But Experts Say Generic Exports are Safe.

Explainer: PRIP can be the magic pill for drug discovery

Enhancing intellectual property enforcement and offering tax benefits on R&D expenditure can further motivate innovators. Skill development programmes for scientists,…

October 7, 2025 21:20 IST

Indegene stock, ICICI Securities Add rating

Indegene buys BioPharm for $106 mn to boost AI-driven pharma marketing

The deal, executed through Indegene’s subsidiary ILSL Inc., aims to strengthen Indegene’s commercialisation portfolio and expand its AI-powered marketing and…

October 2, 2025 09:42 IST

US tariff on Indian pharma: Nomura sees $100 million tariff risk for Sun Pharma

Nomura warns Sun Pharma faces $100 million risk from potential US tariffs on specialty drugs. Explore the impact on Indian…

September 30, 2025 17:54 IST

Trump built a tariff wall, Indian pharma found a European gate

Large Indian generic exporters are expanding their presence in European markets via a spate of acquisitions in that region, at…

September 30, 2025 05:00 IST

Related News

The “Villain” who beat Vijay Mallya: How Danny Denzongpa built a secret beer empire

Not Thailand or Vietnam: This visa-free country with direct flights is the new favourite destination for Indian travellers

Who is Alexandr Wang? 28-year-old hired for 14 billion US dollar by Mark Zukerberg to lead Meta superintelligence labs

Who is Alexandr Wang? 28-year-old hired for 14 billion US dollar by Mark Zuckerberg to lead Meta superintelligence labs

2025 Asia Artist Awards winners list ful

10th Asia Artist Awards winners: IU, Stray Kids are Artist of the Year; IVE, Ateez snag other daesang

Aadhaar Card Update: Simple step-by-step guide to change your address online without hassle

Aadhaar Card Update: How to change address in Aadhaar Card online in simple steps

Why did RBI Governor say India’s economy is in ‘rare Goldilocks period’?

Policy24 min ago

RBI Governor Sanjay Malhotra cuts repo rate to 5.25%, describing India’s economy as a “rare Goldilocks period” with high growth and low inflation. GDP growth estimates revised to 7.3% for FY26 and inflation estimates lowered to 2%. This is expected to boost credit expansion in the banking industry.

View all shorts